| Recruiting | Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery NCT07011147 | University of Colorado, Denver | N/A |
| Not Yet Recruiting | Evaluation of the Effect of Nurse Coaching Program on Self-management and Skin Care Behaviors in Patients With NCT06717256 | Necmettin Erbakan University | N/A |
| Enrolling By Invitation | Scaling Telehealth Models to Improve Co-morbid Diabetes and Hypertension in Immigrant Populations (Phase II) NCT06542939 | NYU Langone Health | N/A |
| Completed | Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus NCT06498284 | Hua Medicine Limited | Phase 1 |
| Recruiting | The EMPA-FIT Study NCT06846411 | Seoul National University Bundang Hospital | Phase 4 |
| Unknown | Differences in Postprandial Glucose Changes NCT05957224 | The University of The West Indies | N/A |
| Completed | Development and Exploration of the Effectiveness and Feasbility of a Digital Intervention for Type 2 Diabetes NCT05364476 | EVYD Technology | N/A |
| Completed | TARDIS - Photo Elicitation and Intervention NCT06972251 | VA Office of Research and Development | N/A |
| Unknown | Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy NCT04667143 | Jiangsu HengRui Medicine Co., Ltd. | Phase 3 |
| Unknown | ´Sit Less, Move More' at Work: mHealth Intervention on Office Employees With Diabetes Type 2. NCT04092738 | Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | N/A |
| Completed | Fenofibrate in Type 2 Diabetes NCT03829514 | Medical University of South Carolina | Phase 4 |
| Completed | A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Participants With Type 2 NCT03596177 | MedImmune LLC | Phase 2 |
| Completed | Insulin Sensitivity During Hyperbaric Oxygen Compared to Hyperbaric Air NCT03138746 | University of Adelaide | — |
| Completed | Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308 NCT03616392 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | GOLO Open-Label Pilot 1 NCT03478202 | Golo | N/A |
| Completed | Effects of Mild Hypoglycaemia on Cognitive Function in Type 2 Diabetes NCT03014011 | Bispebjerg Hospital | N/A |
| Terminated | Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema NCT02985242 | Hannover Medical School | Phase 4 |
| Completed | Episodic to Real-Time Care in Diabetes Self-Management NCT03012074 | Duke University | N/A |
| Withdrawn | Measuring Patient Engagement in Diabetes Care NCT02988427 | Northwestern University | — |
| Unknown | Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Di NCT02946632 | Korea University Anam Hospital | Phase 3 |
| Completed | Impact of Periodontal Therapy on Patients With Diabetes NCT04830969 | State University of New York at Buffalo | Phase 2 |
| Unknown | Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin NCT02854748 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1) NCT02824874 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Voluntee NCT02685774 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Effect of SLC30A8 rs13266634 Genetic Polymorphism on Zinc Supplementation and Glycemic Control in Egyptian Pat NCT03112382 | Cairo University | Phase 4 |
| Completed | Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers NCT02648854 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunte NCT02627027 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunte NCT02565368 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood NCT02650206 | Stanford University | Phase 1 |
| Completed | Impact of Sleep and Meal Timing on Food Intake Regulation NCT02347020 | Columbia University | N/A |
| Unknown | The Effect of n-3 Fatty Acid Supplementation on Serum Levels, and Gene Expression of type2 Diabetes Patient NCT02261545 | Tehran University of Medical Sciences | Phase 4 |
| Completed | Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills NCT02128854 | Medical University of South Carolina | N/A |
| Completed | Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type NCT02144948 | GWT-TUD GmbH | Phase 3 |
| Completed | Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat NCT02175121 | Pfizer | Phase 2 |
| Completed | Microclinic Social Induction Pilot Intervention for Diabetes and Obesity Management in Qatar NCT02175537 | Microclinic International | N/A |
| Withdrawn | Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Type II Diabetes NCT01453751 | Ageless Regenerative Institute | N/A |
| Completed | Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus NCT02036372 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | N/A |
| Withdrawn | Detection of Diffuse Scar in Patients With Diabetes NCT01794091 | Brigham and Women's Hospital | Phase 4 |
| Completed | A Primary Care, EHR- Based Strategy to Promote Safe and Appropriate Drug Use NCT01669473 | Northwestern University | N/A |
| Completed | Technology Intensified Diabetes Education Study in African Americans NCT02088658 | State University of New York at Buffalo | N/A |
| Unknown | Collection of Performance Data From the Integrated Sensor and Infusion Set. TRIAL 4 NCT01775059 | Medtronic Diabetes R&D Denmark | N/A |
| Completed | EPA Supplementation on Vascular Inflammation, and Gene Expression of PON2 in Patients With Type II Diabetes Me NCT03258840 | Tehran University of Medical Sciences | N/A |
| Completed | VERifynow in DIabetes Non-responsiveness: a Study on Switching From Clopidogrel to Prasugrel NCT01684813 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Phase 4 |
| Completed | Diabetes Mellitus - A Diagnosis Trial by Means of Non Invasive Measurements NCT02028091 | Medical University of Vienna | — |
| Completed | Bioequivalence Study for Acarbose / Metformin FDC NCT01728740 | Bayer | Phase 1 |
| Completed | E-health Care Process Support for Diabetes Type II Patients NCT01566981 | University of Primorska | N/A |
| Completed | Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics NCT01654120 | Mountain Diabetes and Endocrine Center | Phase 4 |
| Unknown | Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate NCT01565096 | ikfe-CRO GmbH | Phase 4 |
| Completed | Micro-Clinic Obesity and Metabolic Risk Prevention Program NCT01651065 | Microclinic International | N/A |
| Completed | A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunt NCT01301092 | Eli Lilly and Company | Phase 1 |
| Completed | Single Dose Escalation Study of PF-05190457 in Healthy Volunteers NCT01247896 | Pfizer | Phase 1 |
| Unknown | The Effects of a Regenerative Mitochondrial Medication on Physiological Parameters in Case of Diabetes Mellitu NCT01197092 | Center for Integrative Medicine, Germany | Phase 2 |
| Completed | Effect of Calcium Polycarbophil on Type II Diabetes Mellitus Control: a Randomized Double-blind Study NCT01252524 | East Carolina University | N/A |
| Completed | Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patient NCT01194258 | Halozyme Therapeutics | Phase 2 |
| Completed | Phase 4 Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II Diabetic Subjects With Suboptima NCT01066039 | Merck KGaA, Darmstadt, Germany | Phase 4 |
| Completed | Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 NCT01281098 | Association for Innovation and Biomedical Research on Light and Image | Phase 2 |
| Completed | Mechanisms of Glycemic Improvement After Gastrointestinal Surgery NCT01025999 | University of Washington | — |
| Active Not Recruiting | Multicenter Research Study to Build a Repository to Study Chronic Diseases in Indiana NCT01386801 | Fairbanks Institute | — |
| Unknown | Predictors of Future Type 2 Diabetes Mellitus in Circassians Minority in Israel NCT01311401 | Ziv Hospital | — |
| Terminated | Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With NCT00970424 | Forest Laboratories | Phase 3 |
| Terminated | Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With NCT00947557 | Forest Laboratories | Phase 3 |
| Completed | Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic Patients NCT00649909 | Hadassah Medical Organization | — |
| Completed | Telephone Delivered Behavioral Skills Intervention for Blacks With T2DM NCT00929838 | State University of New York at Buffalo | N/A |
| Completed | Multifactorial Treatment of Cardiovascular Risk in Diabetic Patients: Identification of Treatment Non-Responde NCT00660790 | Medical University of Graz | — |
| Completed | An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes NCT00642278 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 2 |
| Completed | Jordan Diabetes Microclinic Project NCT01596244 | Microclinic International | N/A |
| Terminated | Diabetes Mellitus Type II and Tissue Oxygenation NCT00554697 | The Cleveland Clinic | — |
| Completed | Study of INT-747 in Patients With Diabetes and Presumed NAFLD NCT00501592 | Intercept Pharmaceuticals | Phase 2 |
| Completed | Comparison of Apidra to Regular Insulin in Hospitalized Patients NCT00528918 | Carl T. Hayden VA Medical Center | N/A |
| Completed | Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy NCT00237952 | Chang Gung Memorial Hospital | N/A |
| Completed | The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM) NCT00131287 | ECbiotech Taiwan | Phase 3 |
| Completed | LANN-study: Lantus, Amaryl, Novorapid, Novomix Study NCT00151697 | Rijnstate Hospital | Phase 3 |
| Completed | Rosiglitazone to Reverse Metabolic Defects in Diabetes NCT00094796 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Completed | Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED) NCT00086515 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) NCT00081328 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
| Completed | A Safety and Efficacy Study of T0903131 (INT131) Besylate to Treat Type 2 Diabetes Mellitus NCT00952445 | InteKrin Therapeutics, Inc. | Phase 2 |
| Completed | Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM NCT00577590 | Washington University School of Medicine | N/A |
| Terminated | Dyslipidemia in Type 2 Diabetes (0767-034) NCT00547274 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | A Study of MK0431 in Patients With Type 2 Diabetes (0431-010) NCT00482079 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | 20 Week Bridging Study in Type II DM NCT00563225 | Sanofi | Phase 3 |
| Completed | Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients NCT00189774 | Astellas Pharma Inc | Phase 2 / Phase 3 |